In vitro antiviral activity of fullerene amino acid derivatives in cytomegalovirus infection

Antibiotiki i Khimioterapiya

Volumn 49, Issue 8-9, 2004, Pages 13-20

  Medzhidova, M G ^a   Abdullaeva, M V ^a   Fedorova, N E ^a   Romanova, V S ^a   Kushch, A A ^a  

^a NONE

Author keywords

Amino acid derivatives; Cytomegalovirus infection; Fullerene C60; in vitro antiviral activity

Indexed keywords

CYTOMEGALOVIRUS;

AMINO ACID; ANTIVIRUS AGENT; FULLERENE C60; FULLERENE DERIVATIVE; WATER;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; SOLUBILITY; TIME; VIROLOGY;

AMINO ACIDS; ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOPATHOGENIC EFFECT, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FULLERENES; HUMANS; SOLUBILITY; TIME FACTORS; WATER;

EID: 20844444794     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ho M. Epidemiology of cytomegalovirus infection. Rev Infect Dis 1990; 12: Suppl 7: S701-S710.
2. Gaytant M. A., Steegers E. A., Semmekrot B. A. et al. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002; 57: 4: 245-256.
3. Faulds D., Heel R. C. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990; 39: 4: 597-638.
4. Chrisp P., Clissold S. P. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991; 41: 1: 104-129.
5. De Clercq E. Antivirals for the treatment of herpes virus infections. J Antimicrob Chemother 1993; 32: Suppl A: 121-132.
6. de Smet M. D., Meenken C. J., Van den Horn G. J. Fomivirsen: a phosphorothioate oligonucleotide for the treatment of CMV retinitis. Ocul Immunol Infiamm 1999; 7: 3-4: 189-198.
7. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 1999; 12: 3: 286.
8. Chen Y. W., Hwang K. C., Yen C. C., Lai Y. L. Fullerene derivatives protect against stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regul Ingegr Comp Physiol 2004; 287: 1: R21-26.
9. 60 fullerene in aqueous solutions. Biochem Biophys Res Commun. 2003; 303: 2: 562-566.
10. Hsu H. C., Chiang Y. Y., Chen W. J., Lee Y. T. Water-soluble hexasulfobutyl [60] fullerene inhibits plasma lipid peroxidation by direct association with lipoproteins. J Cardiovasc Pharmacol 2000; 36: 4: 423-427.
11. Foley S., Crowley C., Smaihi M. et al. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002; 294: 1: 116-119.
12. 60 fullerene on the microbial growth in vitro. Ann Pharm Fr 2000; 58: 3: 170-175.
13. 60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity. J Neurosci Res 2003; 71: 1: 121-126.
14. Tsao N., Luh T. Y., Chou C. K. et al. Inhibition of group A Streptococcus infection by of carboxyfullerene. Antimicrob Agent Chemother 2001; 45: 6: 1788-1793.
15. Tsao N., Luh T. Y., Chou C. K. et al. In vitro action of carboxyfullerene. J Antimicrob Chemother 2002; 49: 4: 641-649.
16. Dugan L. L., Lovett E. G., Quick K. L. et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Related Disord 2001; 7: 3: 243-246.
17. Bosi S., Da Ros T., Spalluto G. et al. Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60] fullerene derivatives. Bioorg Med Chem Lett. 2003; 13: 24: 4437-4440.
18. Russian source
19. Russian source
20. Russian source
21. Russian source
22. 60 amino acid derivatives on the structure and functions of biomembranes. Mol Mat 1998; 11: 111-116.
23. Russian source
24. 60. J Nanoparticle Research 2003; 5: 561-566.
25. Snoek R., Neyts J., De Clercq E. Strategies for the treatment of cytomegalovirus infections. In book: Multidisciplinary Approach to Undestanding Cytomegalovirus Desease. Eds S. Michelson, S.A. Plotkin, Amsterdam, 1993; 269-278.
26. Yamashita K., Iwataki T., Hatta T. et al. Fluorescence microscopic visualization of a DNA-cationic fullerene complex. Nucleic Acids Symp Ser 2000; 44: 173-174.
27. Jensen A., Wilson S. R., Schuster D. I. Biological applications of fullerenes. Bioorg Med Chem 1996:4: 6: 767-779.